Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 767-770

  Guzel, Ali Irfan ^a   Kuyumcuoǧlu, Umur ^b   Ç Elik, Yusuf ^c  

^a Diyarbakir Devlet Hastanesi   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

^c DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Clinical features; Hirsutism; PCOS; Risk factors

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE;

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIRSUTISM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; OVARY POLYCYSTIC DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STUDENT T TEST; TURKEY (REPUBLIC); ADOLESCENT; BLOOD; HOSPITALIZATION;

ADOLESCENT; ADULT; BODY MASS INDEX; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMANS; LUTEINIZING HORMONE; MENARCHE; POLYCYSTIC OVARY SYNDROME; PROLACTIN; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TESTOSTERONE; YOUNG ADULT;

EID: 84863225160     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2077-5     Document Type: Article

References (23)

1. Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353.
2. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853-861.
3. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47.
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749.
5. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438.
6. Ferriman DM, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol 21:1440-1447.
7. Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694-2698.
8. Goodman NF, Bledsoe MB, Cobin RH, Futterweit W, Goldzieher JW, Petak SM, Smith KD, Steinberger E (2001) American Association of Clinical Endocrinologists Hyperandrogenic Disorders Task Force. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract 7:120-134.
9. Balen A (1999) Pathogenesis of polycystic ovary syndrome the enigma unravels? Lancet 353:966-967.
10. Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology and management. Am J Obstet Gynecol 140:815-830.
11. Lee AT, Zane LT (2007) Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol 8:201-219.
12. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821-826.
13. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011.
14. Solomon CG (1999) The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risk. Endocrinol Metab Clin North Am 28:247-265.
15. Lobo RA, Carmina E (2000) The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132:989-993.
16. Lowenstein EJ (2006) Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome. Dermatol Ther 19:210-223.
17. Kopera D, Wehr E, Obermayer-Pietsch B (2010) Endocrinology of hirsutism. Int J Trichol 2:30-35.
18. Coskun A, Ercan O, Arikan DC, O ̈ zer A, Kilinc M, Kiran G, Kostu B (2011) Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women. Eur J Obstet Gynecol Reprod Biol 154:167-171.
19. Al-Ruhaily AD, Malabu UH, Sulimani RA (2008) Hirsutism in Saudi females of reproductive age: a hospital-based study. Ann Saudi Med 28:28-32.
20. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate AM et al (2004) Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes 53:2353-2358.
21. Aydogdu I, Ozkan H, Aral Y, Tasni C, Yalcin F (1992) Hirsutismuslu Olgularda Siproteron Asetat, Spironolakton ve Bromokriptin Tedavisi. T Klin Jinekol Obst 2:133-8.
22. Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF (2006) Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med 166(19):2081-2086.
23. Hudecova M, Holte J, Olovsson M, Sundström Poromaa I (2009) Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 24(5):1176-1183